Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

FvSynBio Metabolic Engineering of the Edible Fungus Fusarium venenatum for Synchronous Bioproduction of Haemoglobin and Mycoproteins

Coordinator
Imperial College of Science Technology and Medicine, United Kingdom
Runs
1 May 2026 to 30 April 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101274539

What the project is doing

In the project's own words, from its summary on CORDIS.

Global food security is facing mounting challenges from population growth, climate change, and the environmental costs associated with conventional agriculture. Fungal mycoproteins offer sustainable, protein-rich alternatives; however, current products are limited by their pale colour, mild flavour, and low haem iron content, which requires the use of costly additives. This project, FvSynBio, pioneers the metabolic engineering of fungi to enable the synchronous bioproduction of haemoglobin (Hb) and mycoprotein within a single biomass.

By integrating advanced CRISPR/Cas9 and synthetic biology tools, the project will construct stable genetic modules, optimise metabolic pathways and fermentation processes, and validate scalability and economic viability through techno-economic assessment. This innovation eliminates blending steps, reduces production costs, and delivers meat substitutes with enhanced sensory and nutritional properties, including authentic red colour, meaty flavour, and improved iron nutrition.

The originality lies in establishing fungi as a platform for functional Hb expression, significantly expanding its genetic toolbox and positioning it at the forefront of fungal synthetic biology. Outcomes include engineered strains, robust fermentation protocols, and an open, transferable toolkit benefiting the wider microbial biotechnology community. Impact extends beyond science: reducing reliance on animal agriculture, contributing to the EU Green Deal, and unlocking cost-effective, climate-resilient protein sources for global markets.

Topics

Who is involved

OrganisationCityCountryRole
Imperial College of Science Technology and MedicineLondonUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI